Advisory Services Network LLC Purchases 769 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Advisory Services Network LLC grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 22,129 shares of the company’s stock after purchasing an additional 769 shares during the period. Advisory Services Network LLC’s holdings in GE HealthCare Technologies were worth $1,730,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Shelton Capital Management raised its holdings in shares of GE HealthCare Technologies by 0.4% during the 4th quarter. Shelton Capital Management now owns 57,508 shares of the company’s stock valued at $4,496,000 after buying an additional 217 shares in the last quarter. Rathbones Group PLC boosted its stake in GE HealthCare Technologies by 24.5% in the fourth quarter. Rathbones Group PLC now owns 278,337 shares of the company’s stock worth $21,760,000 after buying an additional 54,748 shares in the last quarter. Invesco Ltd. grew its position in GE HealthCare Technologies by 18.4% during the fourth quarter. Invesco Ltd. now owns 8,067,927 shares of the company’s stock valued at $630,751,000 after acquiring an additional 1,252,613 shares during the last quarter. Bank of Montreal Can raised its stake in shares of GE HealthCare Technologies by 3.5% during the fourth quarter. Bank of Montreal Can now owns 733,006 shares of the company’s stock worth $57,306,000 after acquiring an additional 25,053 shares in the last quarter. Finally, Federated Hermes Inc. lifted its holdings in shares of GE HealthCare Technologies by 115.3% in the 4th quarter. Federated Hermes Inc. now owns 71,733 shares of the company’s stock worth $5,608,000 after acquiring an additional 38,415 shares during the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 0.9 %

GEHC opened at $62.81 on Friday. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The business has a 50 day simple moving average of $81.75 and a two-hundred day simple moving average of $84.06. The firm has a market capitalization of $28.72 billion, a price-to-earnings ratio of 14.51, a PEG ratio of 3.19 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. Analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be given a $0.035 dividend. The ex-dividend date is Friday, April 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.22%. GE HealthCare Technologies’s dividend payout ratio is 3.23%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on GEHC shares. Wells Fargo & Company increased their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Citigroup boosted their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Finally, The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and increased their target price for the company from $85.00 to $100.00 in a report on Tuesday, March 11th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $97.73.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.